Prospective comparative study between colposcopy and histopathology for diagnosis of CIN and carcinoma cervix

Authors

  • Kishorkumar Hol Department of Obstetrics and Gynecology, Smt. Kashibai Navale Medical College and General Hospital, Pune, Maharashtra, India
  • Shweta S. Mishra Department of Obstetrics and Gynecology, Smt. Kashibai Navale Medical College and General Hospital, Pune, Maharashtra, India
  • Sameer Darawade Department of Obstetrics and Gynecology, Smt. Kashibai Navale Medical College and General Hospital, Pune, Maharashtra, India
  • Hemant Damle Department of Obstetrics and Gynecology, Smt. Kashibai Navale Medical College and General Hospital, Pune, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20193793

Keywords:

Carcinoma cervix, Cervical biopsy, CIN, Colposcopy, Pap smear

Abstract

Background: Cervical cancer develops from precursor lesions and detection of these lesions is of utmost importance. The detection of precancerous lesions is made with help of screening tests most important include PAP smear and colposcopy. So we conducted this study to understand the role of colposcopy in down staging of Carcinoma cervix.

Methods: We performed a prospective study between Jan 2018 to Dec 2018 on 180 subjects chosen from patients who sought consultation for various gynaecological complaints between age group of 18-60 years. A Pap smear followed by a colposcopy was performed and colposcopic directed biopsies were taken and subjected to histolopathological examination.

Results: Colposcopy had a sensitivity of 83.3%, specificity of 78.5%, PPV of 68.9% for CIN 1. It had a sensitivity of 90.9%, specificity of 95.2%, PPV of 83.33% for CIN 2 and 3 when co related with gold standard histopathology which is much higher as compared to Pap smear.

Conclusions: Colposcopy is an effective tool in down staging of Carcinoma cervix.

References

World cancer report 2014. WHO 2014 Chapter 5.12 ISBN 978-9283204 299. Available at: https://www.who.int/cancer/publications/WRC_2014/en/.

Maurice C, Dicker D. Global burden of disease cancer collaboration Fitz The global burden of cancer 2013. JAMA. 2015;1:505-27.

Olvera A, Cetina L, Coroner J, Duenas G, Onzallz A. Emerging drugs for treatment of cervical cancer. Expert Opin Emerg Drugs. 2015;20:165-82.

Lee JY, Kim HS, Kim K. Safety of less aggressive surgery for stage 1A1 squamous cell carcinoma of cervix. J Obster Gynaecol Res. 2014;40:1382-8.

Sellor JW, Sankaranarayan R. Colposcopy and treatment of CIN: A beginners manual. IARC Press, Lyon. 2003:13-21.

Kumar K, Iyer VK, Bhatia N, Kriplani A, Verma K. Comparative evaluation of small cytology and hybrid capture for diagnosis of cervical cancer. Indian J Med Res. 2007;126:39-44.

Rasna D, JyothiV, Martha J. A strategic assessment of cervical cancer prevention and treatment. Stratergies Repro Health. 2005;2:11.

Moss EL, Dhar KK, Byrom J, Jones PW, Redman CW. The diagnostic accuracy of colposcopy in previously treated cervical intraepithelial neoplasia. J LOW Genit Tract Dis. 2009;13(1):5-9.

Boonlikit S. Correlation between reidcolposcopic index and histologic results from colposcopically directed biopsies in differentiating high grade from low grade squamous intraepithelial lesion at Rajavithihospital. Medassoc Thai. 2011;94(Suppl2):S59-S65.

Downloads

Published

2019-08-26

Issue

Section

Original Research Articles